TipRanks on MSN
SCYNEXIS halts phase 3 MARIO trial, raising new questions for ibrexafungerp’s growth path
SCYNEXIS Inc ($SCYX) announced an update on their ongoing clinical study. Study Overview: SCYNEXIS Inc. (SCYX) is running a Phase 3 trial titled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback